blue | bleu

Jason Karamchandani, MD

Contact Information

Email: jason.karamchandani [at] (Jason Karamchandani)
Tel.: (514) 398-5348
Recent Publications: Google Scholar, PubMed
Academic Affiliations: Neuropathology
Clinical Interests: 
Research Group: Brain TumorRare Neurological Diseases

Dr. Jason Karamchandani is an Assistant Professor in the Department of Pathology, and is a neuropathologist at The Montreal Neurological Institute and Hospital. His clinical specialty is neuropathology and anatomic pathology. His research employs bio-informatic data to identify and to characterize biomarkers relevant to classification and prognosis of brain tumors and neuromuscular disorders. His laboratory at the Neuro will examine pathologies of both the central nervous system as well as neuromuscular disease.

Dr. Karamchandani also currently serves as the director of immunohistochemistry and special stains for the MUHC, program director for the McGill Anatomic Pathology residency program, and on the tissue and bio-banking committee of the MUHC research ethics board.

A graduate of Harvard University, where he received his AB Honours degree in biochemistry cum laude, Dr. Karamchandani earned his medical degree at Stanford University School of Medicine where he was class valedictorian. At Stanford, he pursued residency training in anatomic pathology, as well as fellowship training in surgical pathology and neuropathology.

Among his scientific achievements, Dr. Karamchandani has authored or co-authored 40 publications in peer-reviewed journals. He has published three book chapters, with the most recent describing the molecular alterations and clinical tests in tumors of the central nervous system, and tumors of the spinal cord.

The Montreal Neurological Institute & Hospital is a McGill University research and teaching institute; delivering the highest quality of care to patients, as part of the Neuroscience Mission of the McGill University Health Centre. The Neuro is proud to be a Killam Institution, supported by the Killam Trusts.